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The aim of this study is to analyze the relationship between socio-demographic, clinical and psychosocial
variables in patients with Type 2 Diabetes and to establish comparative patterns between genders with this
disorder.
Patients from a primary care center were assessed through a researcher design form and through the
HADS, the ESSS and the PSQI.
A total of 90 patients with Type 2 Diabetes were enrolled in this study (50% women), with a mean age
of 56.67±6.41 years. The HADS depression presented a score of 3.77±2.98 and 6.70% of the sample
revealed depression symptoms. As to anxiety, the HADS presented scores of 7.27±5.07 with 36.60% of
the subjects revealing anxiety symptoms. Regarding social support, the results were positive and similar
between genders. When it comes to sleep, the sample presented a PSQI of 8.68±2.87, with 73.30% of
patients revealing poor sleep quality and 24.40% showing a sleep disorder. When comparing genders,
women had higher anxiety (♀ 9.73±5.58; ♂ 4.80±2.91; p=0.000) and depression scores (♀ 4.26±2.69;
♂ 3.26±3.19; p=0.026), and worse sleep quality (♀ 9.88±7.46; ♂ 7.46±2.34; p=0.000).
In conclusion, we can state that anxiety symptoms are very prevalent in patients with Type 2 Diabetes and
women are more vulnerable to anxiety, depression symptoms and poor sleep quality.
Key-words: Type 2 Diabetes, Anxiety, Depression, Social support, Sleep.
INTRODUCTION
Type 2 Diabetes is a metabolic disorder with multiple etiologies marked by chronic hyper -
glycemia with carbohydrates metabolic disorders, lipid and protein resulting from deficiencies in
the secretion or action of insulin, or both (Zimmernan & Walker, 2002). It is estimated that
approximately 52 million of Europeans live with Diabetes with similar numbers of men and
women (8.40% vs. 7.80%) between 20-79 years of age (Jakab, 2010), and approximately 12.30%
of Portugal’s population has Diabetes with 90% having Type 2 Diabetes. This can be attributed to
rapid social and cultural changes, population ageing, increasing urbanization, modification of
alimentary habits, physical activity reduction and increased unhealthy life styles (Observatório
Nacional da Diabetes, 2010). Furthermore, Type 2 Diabetes is strongly associated with obesity
(Fagot-Campagna et al., 1998), and obesity stands out as a risk factor for DM2 (Hussain, Hydrie,
Claussen, & Asghar, 2010).
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When considering the relationship between Type 2 Diabetes and psychosocial factors, the
studies are unanimous in pointing to a high association of anxiety/depression symptoms and these
being more prevalent than in normal populations (Amorim & Coelho, 2008; Zimmernan & Walker,
2002) and recurring over time (Peyrot, 2003; Peyrot & Rubin, 1999). Anxiety/depression
symptoms in Type 2 Diabetes can be associated with a poor glycemia control, low adherence to
the therapeutic regimen, disorder aggravation in the long run (Amorim & Coelho, 2008) and
quality of life decrease (Goldney, Phillips, Fisher, & Wilson, 2004). Studies suggest that
individuals with low economic income (Nascimento, Chaves, & Grossi, 2009), older patients
(Ricco, Miyazaki, & Silva, 2004), and those with less social support (Amorim & Coelho, 2008),
poor glycemia control (Tellez-Zenteno & Cardiel, 2002), and inactivity (Amorim & Coelho, 2008)
are more vulnerable to depression symptoms. There is no agreement regarding the relationship
between depression symptoms and educational level (Amorim & Coelho, 2008; Nascimento et al.,
2009; Ricco et al., 2004) or marital status (Amorim & Coelho, 2008; Nascimento et al., 2009;
Tellez-Zenteno & Cardiel, 2002). However education level and marital status do not reveal any
association with anxiety symptoms in patients with Diabetes (Amorim & Coelho, 2008). Literature
points to an association of bad alimentary habits (Papelbaum et al., 2005) and low social support
as causes of anxiety symptoms (Amorim & Coelho, 2008).
When it comes to comparisons between genders, some studies show no differences regarding
depression (Ramos & Ferreira, 2011) and anxiety symptoms (Khuwaja & Kadir, 2010; Ramos &
Ferreira, 2011), while the majority of the authors suggest a higher prevalence of depression
(Amorim & Coelho, 2008; Gucciardi, Wang, DeMelo, Amaral, & Stewart, 2008; Khuwaja &
Kadir, 2010; Roupa et al., 2009), as well as a higher prevalence of anxiety in women (Amorim &
Coelho, 2008; Roupa et al., 2009). The studies also suggest that women have a higher probability
of having a family history of Diabetes and of having a better social support system from care
givers (Gucciardi et al., 2008).
The literature highlights a significant association between a good social support system and
behaviors that promote health and well-being in patients with Type 2 Diabetes (Schiotz, Bogelund,
Almdal, Jensen, & Willaing, 2012), positive associations with self-efficiency (Park & Kim, 2012),
and negative associations with depression symptoms and the adhesion to the therapeutic regimen
(Osborn & Egede, 2012).
Data suggests a poor sleep quality in patients with Type 2 Diabetes with PSQI scores ≥5, with
a high prevalence of sleep disturbances ranging from 52-71% (Barone & Menna-Barreto, 2011;
Knutson, Ryden, Mander, & Van Cauter, 2006).
Taking into account the bibliographic research that focuses predominantly on the analysis of
depression and anxiety, evidence suggests a high prevalence in patients with Type 2 Diabetes.
Differences between sexes have been sometimes contradictory or inconclusive, and the same
happens with the analysis of the social support, sleep quality, and its relationship with several
socio-demographic, clinical and psychosocial variables. The aim of this study is to analyze the
relationship between socio demographic, clinical and psychosocial variables and to establish
comparative patterns between the gender of patients with Type 2 Diabetes.
RESEARCH DESIGN AND METHODS
Subjects
The selection of the sample was based on the convenience sampling method. The patients were
recruited in the primary care center Extensão de Saúde Dr. Vale Lima from the ACES Cávado III
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Barcelos / Esposende, Portugal. The primary care center covers a region classified as
predominantly rural, with about 5.300 users, of which 300 are patients with type 1 and Type 2
Diabetes. Inclusion criteria were predefined as follows: (1) established diagnosis of Type 2
Diabetes for more than 1 year; (2) age between 18-65 years; (3) absence of cancer problems; and
(4) informed consent to participate in the study. The sample was reduced from 300 to 125
patients, which culminated in 90 subjects (50% women) that agreed to take part in the study. The
investigation followed the ethics and deontological principles required on scientific research.
METHODS
Socio demographic and clinical characteristics
Using a researcher-design form, participants gave information about their age, gender, studies
(≤1st degree; and ≥2nd degree), marital status (married / common law marriage; unmarried),
professional status (employed; unemployed; retired), and household (living with partner; living
with restricted family – sons and partner; living with extended family – sons, partners and
others). In the same way, a clinical data sheet was designed to collect information about the
number of years with Type 2 Diabetes, number of years in pharmacological treatment, and
family with Type 2 Diabetes.
Psychosocial characteristics
Anxiety and depression symptoms were assessed using the Hospital Anxiety and Depression
Scale (HADS) (Pais-Ribeiro et al., 2007; Zigmond & Snaith, 1983), that consists of 14 items
divided into two subscales of seven items. Each subscale ranges from 0-21, and a score between
0-7 points is within normal values. Values between 8-10 indicate possible anxiety / depression,
and ≥11 suggests clinical anxiety / depression (Snaith & Zigmond, 1994).
Social support was evaluated with the Satisfaction with Social Support Scale (ESSS) (Pais-
Ribeiro, 1999) and it consists of 15 items divided into four dimensions: satisfaction with friends,
intimacy, satisfaction with family and social activities. Each item is scored from 1 (totally agree)
to 5 (totally disagree). A global score can also be obtained (total ESSS), between 15-75 points,
with high scores indicating higher levels of perceived social support, and scores ≥51 suggesting
a good social support.
Sleep was assessed through the Pittsburgh Sleep Quality Index (PSQI) (Buysse, Reynolds,
Monk, Berman, & Kupfer, 1986) and measured both its qualitative and quantitative aspects in
the last month, and comprises seven dimensions: overall sleep quality, sleep latency, duration
of sleep, sleep efficiency, sleep disturbance, need meds to sleep, day dysfunction due to
sleepiness, and a total score. Each dimension is scored from 0-3 and the total score varies from
0-21, with 21 being the worse quality of sleep possible. Scores >5 suggest a poor sleep quality
and >10 determine the presence of a sleep disorder (Buysse, Reynolds, Monk, Berman, &
Kupfer, 1989).
The original and Portuguese version of the instruments had adequate psychometric properties:
HADS (Pais-Ribeiro et al., 2007; Zigmond & Snaith, 1983); ESSS (Pais-Ribeiro, 1999); PSQI
(Bertolazi et al., 2011; Buysse et al., 1986).
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Procedures
The assessment was performed in a single moment. The subjects of the sample fulfilled the
evaluation protocol that was composed by the researcher-design form regarding the socio
demographic and clinical variables and the HADS, the ESSS and the PSQI.
Statistical analysis
The presentation of socio demographic, clinical and psychosocial variables was based on
observed frequencies and percentages in the case of categorized / ordinal variables, and the mean
and standard deviation in the case of quantitative variables. The internal consistency was assessed
using the Cronbach’s Alpha, considering acceptable values ≥0.70 (Nunnally & Bernstein, 1994).
The bivariate relationships between socio demographic, clinical and psychosocial variables were
calculated by the U Mann-Whintey, the Chi-Square test and the r Spearman.
The statistical significance level was p<0.05, and the statistical analysis was made using the
SPSS version 17.0 for Windows.
RESULTS
The sample studied was formed by 90 patients with Type 2 Diabetes, with a mean age of 56.67
years (SD=6.41), and 50% were women. The sample majority was married / common law marriage
(86.70%), had studies ≤1st degree (74.40%), and living with restricted family (65.60%). When it
comes to the employment status a homogeneous distribution was observed between employed
(40%), unemployed (25.60%) and retired patients (34.40%).
Data regarding clinical variables, revealed that the sample presented a mean of 8.96 years with
Type 2 Diabetes (SD=6.44; range between 2-32 years), a mean of 8.36 years on pharmacological
treatment (SD=5.54; range between 1-32 years), and the majority of sample patients had relatives
with Type 2 Diabetes (68.90%).
When considering the psychosocial variables, it should be mentioned that the HADS depression
(a=0.632), the ESSS intimacy (a=0.568) and the total PSQI (a=0.555) revealed scores of internal
consistency <0.70. It should be stressed that the sample presented low levels of anxiety and
depression symptoms (scores <8 points), with the HADS anxiety revealing mean scores of 7.27
(SD=5.07) and the HADS depression reporting mean scores of 3.77 (SD=2.98). Considering that
the HADS score was above 8 points, suggests the presence of anxiety / depression symptoms. It
was verified that 35.60% of the sample (n=32) revealed anxiety symptoms and 6.70% presented
depression symptoms (n=6). For social support, it was observed scores of 66.87 in the total ESSS
(SD=8.22) and scores ≥3.97 in its sub scales. For sleep quality, the total PSQI score was 8.68
(SD=2.87), 73.30% (n=66) had poor sleep quality (total PSQI scores between 5-10), and 24.40%
(n=22) revealed sleep disorder (total PSQI score >10).
The results show, by assessing males, that the sample had a mean age of 56.75 years (SD=6.58),
mostly married (n=40), with low educational levels (34 with studies ≤1st degree). The majority
were employed (n=23), living in restricted families (n=28), and had relatives with Type 2 Diabetes
(n=30). As to the female patients, they had a mean age of 56.57 years (SD=6.30), were mostly
married (n=38), with low study levels (33 with studies ≤1st degree), living in restricted families
(n=31), and they had relatives with Type 2 Diabetes (n=32). However, as far as professional status
is concerned, women presented a homogeneous distribution (Table 1).
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When gender-related outcomes were compared, significant statistical differences weren’t found
regarding the clinical variables and the psychosocial variables such as social support, overall sleep
quality, duration of sleep, and sleep efficiency (PSQI). Nevertheless, women revealed higher
depression symptoms scores (M=9.73; p=0.000), in anxiety symptoms (M=4.26; p=0.026) and in
the PSQI scores as follows: total PSQI (M=9.88; p=0.000); sleep latency (M=1.37; p=0.000); sleep
disturbance (M=1.80; p=0.039); need meds to sleep (M=0.60; p=0.036); and day dysfunction due
to sleepiness (M=1.11; p=0.015) (Table 1).
By proceeding to the analysis of the relationship between the anxiety and depression
symptoms, with the socio-demographic and clinical variables, it was only observed that
unemployed patients presented significantly higher levels of depression symptoms when
compared with employed ones (5.03±3.42 vs. 2.92±2.66; p<0.050).
By examining the relationship between the social support indicators and the socio-
demographic and clinical variables, the employed patients presented significantly lower scores
than unemployed patients in the total ESSS (p<0.050). The patients with family with Type 2
Diabetes revealed lower scores in the ESSS intimacy (p<0.050). The patients living with
partners presented higher satisfaction with social activities than patients living with restricted
families (p<0.050). Employed patients had lower satisfaction with family than unemployed and
retired patients (p<0.050) (Table 2).
As to the relationship between the PSQI and the studied variables, the employed subjects
revealed a better quality of sleep than unemployed subjects in the dimensions as follow: total
PSQI (M=7.50 vs. M=10.30; p<0.050); overall sleep quality (M=0.97 vs. M=1.39; p<0.050);
sleep latency (M=0.58 vs. M=1.48; p<0.050); day dysfunction due to sleepiness (M=0.72 vs.
M=1.26; p<0.050). The employed patients also presented better quality of sleep scores when
compared with retired patients in the dimensions: overall sleep quality (M=0.97 vs. M=1.26;
p<0.050); need meds to sleep (M=0.11 vs. M=0.74; p<0.050). Retired patients presented a better
sleep efficiency than employed (M=2.55 vs. M=2.97; p<0.050) and unemployed patients
(M=2.55 vs. M=3.00; p<0.050). For the relationship between sleep quality and the household,
it was only observed that subjects living with partners had a better sleep efficiency than subjects
living in restricted families (M=2.60 vs. M=2.92; p<0.050) (Table 3).
When the correlation analysis between variables was made (Spearman R), the results revealed
that the anxiety symptoms were positively correlated with depression symptoms (r=0.411;
p<0.010) and all sleep quality indicators, with the exception of need meds to sleep. As far as
depression symptoms is concerned, besides positively correlating with anxiety symptoms, as it
was mentioned before, it was also positively correlated with all sleep quality indicators, except
that of duration and efficiency of sleep. A positive correlation between depression symptoms and
the age of patients was also observed (r=0.254; p<0.050), and a negative correlation with
satisfaction with friends (r=-0.240; p<0.050). Besides being correlated with depression
symptoms, social support presented positive correlations between the satisfaction with family
and the overall sleep quality (r=0.384; p<0.010) and with age (r=0.232; p<0.050). As to sleep
quality, negative correlations were observed between the efficiency of sleep and the variables
as follows: number of years with Type 2 Diabetes (r=-0.213); number of years on
pharmacological treatment (r=-0.228); and the patients’ age (r=-0.244) for a p<0.050. Sleep
disturbance revealed positive correlations with the number of years on pharmacological
treatment (r=0.218; p<0.050). Positive correlations between a high number of PSQI indicators
was also noted (Table 4). To conclude, the number of years with Type 2 Diabetes was positively
correlated with the number of years in pharmacological treatment (r=0.938; p<0.010) and with
patient’s age (r=0.261; p<0.050), and the number of years in pharmacological treatment was
positively correlated with the age of the subjects from the sample (r=0.293; p<0.010) (Table 4).
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TABLE 1
Comparative analysis between genders (socio-demographic, clinical and psychosocial variables)
Men Women
n=45 n=45 p
n (%) p n (%) p
Socio-demographic variables
Marital status
Married / Common law marriage 40 (44.50) 38 (42.20) 0.821
0.000 0.000
Not married 5 (5.60) 7 (7.80) 0.564
Studies
≤1st degree 34 (37.80) 33 (36.70) 0.903
0.001 0.002
≥2nd degree 11 (12.20) 12 (13.30) 0.835
Professional status
Employed 23 (25.60) 13 (14.40) 0.096
Unemployed 8 (8.90) 0.022 15 (16.70) 0.590 0.114
Retired 14 (15.60) 17 (18.90) 0.590
Household
Living with partner 12 (13.3)0 8 (8.9)0 0.371
Living in restricted family 28 (31.1)0 0.000 31 (34.4)0 0.000 0.696
Living in extended family 5 (5.6)0 6 (6.7)0 0.763
Age M±DP (range) 56.75±6.58 (39-65) 56.57±6.30 (42-65) 0.792
Clinical variables
Years with Diabetes M±DP (range) 8.71±5.63 (2-26) 9.20±7.21 (2-32) 0.961
Years in pharmacological treatment M±DP (range) 8.08±5.64 (1-26) 8.62±7.38 (1-32) 0.906
Family with Diabetes
Yes 30 (33.30) 32 (35.60) 0.799
0.025 0.005
No 15 (16.70) 13 (14.40) 0.705
Psychosocial variables
HADS M±DP (range)
Anxiety 4.80±2.91 (0-11) 9.73±5.58 (0-20) 0.000
Depression 3.26±3.19 (0-15) 4.26±2.69 (0-10) 0.026
ESSS M±DP (range)
Total 65.93±8.48 (39-75) 67.80±7.94 (37-75) 0.235
Intimacy 4.45±0.70 (2-5)-- 4.50±0.82 (1-5)-- 0.444
Social activities 3.90±1.07 (1-5)-- 4.04±1.15 (1-5)-- 0.392
Satisfaction with friends 4.44±0.84 (1-5)-- 4.66±0.69 (1-5)-- 0.299
Satisfaction with family 4.73±0.69 (1-5)-- 4.78±0.45 (3-5)-- 0.996
PSQI M±DP (range)
Total 7.46±2.34 (4-15) 9.88±2.87 (5-18) 0.000
Overall sleep quality 1.08±0.46 (0-2)-- 1.26±0.61 (0-3)-- 0.131
Sleep latency 0.57±0.81 (0-3)-- 1.37±1.13 (0-3)-- 0.000
Duration of sleep 0.64±0.77 (0-3)-- 0.84±0.87 (0-3)-- 0.275
Sleep efficiency 2.77±0.51 (1-3)-- 2.88±0.38 (1-3)-- 0.218
Sleep disturbance 1.51±0.50 (1-2)-- 1.80±0.66 (1-3)-- 0.039
Need meds to sleep 0.17±0.68 (0-3)-- 0.60±1.17 (0-3)-- 0.036
Day dysfunction due to sleepiness 0.68±0.76 (0-3)-- 1.11±0.85 (0-3)-- 0.015
Note. HADS Hospital Anxiety and Depression Scale; ESSS Satisfaction with Social Support Scale; PSQI
Pittsburgh Sleep Quality Index; C1 Overall sleep quality; C2 Sleep latency; C3 Duration of sleep; C4
Sleep efficiency; C5 Sleep disturbance; C6 Need meds to sleep; C7 Day dysfunction due to sleepiness.
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DISCUSSION
Global sample results revealed a higher prevalence of anxiety than depression symptoms
(36.60% vs. 6.70%) and the anxiety symptoms were related to a worse sleep quality with the
exception of need meds to sleep. For its part the depression symptoms were associated with low
satisfaction with friends, with a worse sleep quality, and affected more retired and unemployed
patients. Both anxiety and depression symptoms, and sleep quality aspects, affected significantly
more women than men.
Our findings presented a high prevalence of patients with family with Type 2 Diabetes
(68.90%). In fact, the high prevalence of Type 2 Diabetes within family could be explained by the
sharing of the same genetic predispositions and similar lifestyle habits as their relatives (Kuzuya
& Matsuda, 1982), with some studies suggesting that individuals with an affected first-degree
relative have a 2.3 to 5.5 fold higher risk of developing Type 2 Diabetes, independent of gender,
age, race, body mass index (BMI) and other demographic variables (Valdez, Yoon, Liu, & Khoury,
2007). Unlike Gucciardi et al. (2008), that suggests that women have a higher prevalence of
relatives with a history of Type 2 Diabetes, our data did not found differences between genders.
Our results also contradict the literature, revealing low depression symptoms scores (3.77±2.98),
and taking into consideration the normative data, the scores were within normal values (Zigmond
& Snaith, 1983). As it can be observed, 6.70% of the sample presented depression symptoms
(HADS depression scores ≥8), parameters close to 9.20% reported by Amorim and Coelho (2008)
and in contrast with the studies that presented rates between 43.50 and 68.12% (Khuwaja, Lalani,
et al., 2010; Ramos & Ferreira, 2011; Ricco et al., 2004; Roupa et al., 2009). The anxiety symptoms
scores were higher than the depression symptoms scores (7.27±5.07 vs. 3.77±2.98), but still, as it
happens with the depression symptoms, the scores are within normal values (HADS scores ˂8).
Nonetheless, it should be stated that 36.6% of the sample presented anxiety symptoms (HADS
scores ≥8). Our findings are consistent with the literature that points to a high prevalence of anxiety
symptoms in patients with Type 2 Diabetes, with rates around 57.9% (Khuwaja, Lalani, et al.,
2010).
Nevertheless, when comparative parameters between genders are established, women revealed
significantly higher scores of depression (♀=4.26 vs. ♂=3.26; p=0.026) and anxiety symptoms
(♀=9.73 vs. ♂=4.80; p=0.000). These gender differences, which support a higher prevalence of
depression symptoms in women with Type 2 Diabetes, have been mentioned in previous studies
that pointed out rates twice as high when compared with men (Amorim & Coelho, 2008; Gucciardi
et al., 2008; Khuwaja, Lalani, et al., 2010; Roupa et al., 2009). It is that known that women are
significantly associated with depression in the general populations (Khuwaja & Kadir, 2010) and
among people with Diabetes (Collins, Corcoran, & Perry, 2009). A possible explanation is that
women play gender specific roles, which exposes them to increased work demands and
responsibilities, and the social rule attributed to women allows them to be more emotional and
extroversive (Khuwaja, Lalani, et al., 2010). As mentioned before, women also scored higher than
men on anxiety symptoms, revealing the presence of anxiety which is consistent with the study
of Amorim and Coelho (2008). In this context, it should be mentioned Roupa et al. (2009) that
assessed 310 patients with Type 2 Diabetes (56% women) and women presented anxiety symptoms
scores 3 times higher than men, with HADS scores ≥8 in about 62% female patients. On the other
hand, men had HADS scores ≥8 in only 21% of cases (p<0.001).
When it comes to the relationship between the depression symptoms and the socio demographic
variables, it was only found that employed patients presented significant lower depression scores
(2.92±2.66) than retired ones (5.03±3.42). Amorim and Coelho (2008) had similar results by
assessing a sample of 304 patients with Type 2 Diabetes (186 women) with a mean age of 59.25
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years (SD=8.56). Mostly were married and retired and with low study levels. In this study, active
patients revealed significant lower scores in depression symptoms assessed through the HADS
(p<0.001), which suggests work as a protective factor of the mental area.
Relating to the association between depression symptoms and the psychosocial variables, data
pointed to an association between higher levels of depression symptoms, a lower satisfaction with
friends (r=-0.240; p<0.050), a worse sleep quality assessed through the total PSQI (r=0.404;
p<0.001), a worse overall sleep quality (r=0.263; p<0.050), a worse sleep latency (r=0.300;
p<0.001), higher levels of sleep disturbance (r=0.327; p<0.001), and higher levels of day
dysfunction due to sleepiness (r=0.266; p<0.001). Positive correlations were also observed
between the depression symptoms scores and patient’s age (r=0.254; p<0.050), suggesting higher
levels of depression in elderly patients, which is in line with Tellez-Zenteno and Cardiel (2002),
and represents a negative interference of depression in the psychological functioning of patients
with Type 2 Diabetes .
The social support results, in the present sample, revealed normal scores pointing to satisfactory
outcomes in all the ESSS domains. In a maximum score of 75 points, our sample presented mean
scores of 66.87 (DP=8.22) suggesting high levels of social support satisfaction. One possible
explanation for these findings are the socio-demographic characteristics of the sample, as 78% of
patients were married and 70 % were living with restricted / extended family, which indicates an
extended family support. There were no differences between genders on social support, even
though some studies suggesting better social support by formal caregivers in women with Type 2
Diabetes (Gucciardi et al., 2008). However, employed patients revealed a worse total social support
and a lower family satisfaction than unemployed patients with Type 2 Diabetes (p<0.050). In the
case of satisfaction with family, it was also observed that employed patients revealed less
satisfaction than retired ones (p<0.05), and as patients get older, they perceive higher levels of
satisfaction with family (r=0.232; p<0.050). These findings seem to suggest that being employed
contributes to a worse social support perception, which can be better explained by the labor
demands, limited family lifetime and therefore a smaller social network than unemployed and
retired patients. It is also possible that as patients with Type 2 Diabetes get older, they come to
recognize and appreciate family ties, hence the positive correlation between age and satisfaction
with family assessed through the ESSS.
Almost all sleep quality indicators (with the exception of need meds to sleep) showed positive
correlations with the anxiety symptoms. In the general adult population, the prevalence of sleep
disorders are between 10-20% (Roth, 2008), and sleep disorders coexist with a number of physical
and psychiatric conditions, including anxiety disorders (Walsh, 2004). Moreover, when examining
the sleeping patterns, 90 patients revealed disturbed sleep indices with mean scores above 5
(8.68±2.87), which suggests poor sleep quality and, near the limit of 10 points, suggests the
presence of a sleep disorder (Buysse et al., 1989). Cunha, Zanetti and Hass (2008), in one of the
scarce studies that assessed sleep in Type 2 Diabetes, analyzed 50 patients, 76% women, 52%
married, with ages between 44-79 years, and through the PSQI concluded that the majority (52%)
had a poor sleep quality (score ≥5). Likewise, Knutson et al. (2006) assessed 161 subjects and Vigg
(2003) assessed 220 subjects, both with patients with Type 2 Diabetes, concluded that 71%
presented a PSQI score ≥5, showing that Type 2 Diabetes is associated with sleeping problems
(Barone & Menna-Barreto, 2011). Rajendran et al. (Rajendran, Parthsarathy, Tamilselvan,
Seshadri, & Shuaib, 2012) evaluated 120 patients with Type 2 Diabetes (55 women), with a mean
age of 53.9 years (SD=9.20) and concluded that the average length of Diabetes diagnosis
(7.41±5.90) was positively correlated with the total PSQI score (r=0.181; p<0.050), suggesting that
Diabetes duration has a strong influence on patient’s sleep (the data was independent of variables
as age, gender, body mass index or meds). As in our study, the sample revealed a total PSQI score
of 7.08 and 69% presented a total PSQI score ≥5. This data became even more troubling in
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unemployed patients with Type 2 Diabetes with average total PSQI scores of 10.30, versus the
score of 7.50 in employed patients. The literature suggests that groups from low socio-economic
status have less sleep duration and lower sleep quality (Gellis et al., 2005). Qualified employees
have better sleep levels (Sekine et al., 2006), and unemployed men had a higher prevalence of
sleep-related complaints (Grandner et al., 2010). The results from our study are partially in
accordance with the literature. Our data supports a worse sleep quality in unemployed patients, no
comparative analysis between genders was taken regarding the relationship between professional
status and sleep. Nevertheless, in our study, the employed patients had better sleep patterns than
the unemployed ones in the total PSQI, the overall sleep quality, sleep latency, and in day
dysfunction due to sleepiness (p<0.050). The employed patients also presented a better overall
sleep quality when compared to retired patients (p<0.050). For sleep efficiency, the retired patients
revealed the best scores (p<0.050), with employed and unemployed patients presenting similar
results. On the other hand, the retired patients presented a higher need for sleep medication than
employed patients. It was also observed that women had worse sleep patterns in the total PSQI,
sleep latency, sleep disturbance, need meds to sleep and day dysfunction due to sleepiness
(p<0.039), which is in line with the results from the general female population (Collop, Adkins,
& Phillips, 2004).
When analyzing the relationship between the PSQI and the ESSS, only positive correlations
were observed between overall sleep quality and satisfaction with family (r=0.384; p<0.010). In
other words, patients with worse overall sleep quality expressed a better family social support.
However, as far as sleep efficiency is concerned, patients with more years with Diabetes 
(r=-0.231; p<0.050), with more years in pharmacological treatment (r=-0.228; p<0.050), and older
patients (r=-0.244; p<0.050) revealed better results, which can suggest a positive adaptation
process to Type 2 Diabetes and aging. When it comes to sleep disturbance, patients with more
years in pharmacological treatment had worse scores (r=0.218; p<0.050).
The data observed in this study suggests that, when treating patients with Type 2 Diabetes, a
broad assessment approach should be applied, taking into account factors such as professional
status, gender, age, anxiety/depression symptoms, social support and sleep patterns perception.
Identifying factors that determine the extent of the impact of Type 2 Diabetes will allow the
detection of vulnerable groups/individuals and the design of more effective interventions.
However, this data presents some limitations. Firstly, future studies should include larger
populations for a greater data generalization. Secondly, as coping strategies are important factors
to understand how patients deal with disease and their health in general, these areas should be
taken into account. Thirdly, there’s an important association between obesity and Type 2 Diabetes.
The relative risk of Type 2 Diabetes increases as BMI increases above 23, and association is
stronger in young age groups (Colditz et al., 1990; Ni Mhurchu et al., 2006): the prevalence
increases from 2% in those with BMI of 25 to 29,9kg/m2, to 8% in those with a BMI of 30 to 34,9
kg/m2, and to 13% in those with a BMI greater than 35 kg/m2 (Harris et al., 1998). Investigations
focusing on weight change and Type 2 Diabetes showed that an increase in body weight of 3-20
kg was associated with an elevated risk of incident Type 2 Diabetes, and early obesity and almost
any weight gain after adolescence were risk factors for Type 2 Diabetes (Schienkiewitz, Schulze,
Hoffmann, Kroke, & Boeing, 2006). In fact, Type 2 Diabetes in children and adolescents is an
important public health problem directly related to the epidemic of childhood obesity (Tfayli &
Arslanian, 2009). Moreover, the duration of obesity seems to be a significant risk factor for Type
2 Diabetes, independently of current degree of obesity (Schienkiewitz et al., 2006). For these
reasons, future studies should also include the BMI. Finally, it would be of interest to measure the
impact of Type 2 Diabetes on patient’s health related quality of life.
In conclusion, we can state that anxiety symptoms are very prevalent in patients with Type 2
Diabetes and women are more vulnerable to anxiety, depression symptoms and poor sleep quality.
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Com este estudo pretende-se analisar a relação entre variáveis sociodemográficas, clínicas e psicosso -
ciais em doentes com Diabetes Tipo 2 bem como estabelecer padrões comparativos entre géneros.
Foram avaliados pacientes de uma Unidade de Cuidados Primários através de um formulário próprio
de recolha de informação, da HADS, da ESSS e do PSQI.
A amostra consistiu num total de 90 pacientes com Diabetes Tipo 2 (50% mulheres), com idade média
de 56.67±6.41 anos. A subescala depressão da HADS apresentou um score de 3.77±2.98 e 6.70% da
amostra revelou sintomatologia depressiva. Quanto à ansiedade a HADS apresentou scores de 7.27±5.07
com 36.60% dos sujeitos a manifestarem sintomatologia ansiosa. No que se reporta ao suporte social, os
resultados foram positivos e similares entre géneros. Em relação ao sono, a amostra apresentou um PSQI
de 8.68±2.87, com 73.30% dos pacientes a manifestarem uma pobre qualidade do sono e 24.40% 
a manifestarem uma perturbação do sono. Ao comparar-se géneros, verificou-se que as mulheres
apresentavam maiores scores de ansiedade (♀ 9.73±5.58; ♂ 4.80±2.91; p=0.000) e depressão 
(♀ 4.26±2.69; ♂ 3.26±3.19; p=0.026), e pior qualidade do sono (♀ 9.88±7.46; ♂ 7.46±2.34; p=0.000).
Em conclusão, a sintomatologia ansiosa apresenta uma elevada prevalência em doentes com Diabetes
Tipo 2 e as mulheres são mais vulneráveis à ansiedade, depressão e pior qualidade do sono.
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